Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination | SCLX Stock NewsStockTitan·Sep 22, 2025 at 07:49 PMSCLX-7.94%DECA0.00%
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business CombinationGlobeNewswire·Jun 12, 2025 at 12:30 AMDECA0.00%
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination | DECA Stock NewsStockTitan·Apr 14, 2025 at 08:35 PMDECAU0.00%DECA0.00%
Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.GlobeNewswire·Apr 10, 2025 at 08:00 PMDECAU0.00%DECA0.00%
